Director, US Market Access - New Products & Launch Planning

Gilead Sciences•El Segundo, CA
•Hybrid

About The Position

The Director, New Products & Launch Planning is a portfolio-level individual contributor who represents US Market Access in new product planning, pipeline strategy, and launch readiness for Kite’s future cell therapy assets. Reporting to the Sr Director, Head of US Payer, Value, and Access Strategy, this role ensures US access considerations are integrated early into global planning, evidence generation, launch strategy, commercialization assumptions, and cross-functional decisions. The Director is the primary US Market Access lead for pre-launch and launch planning for longer-range products, working across global and US teams and functions. The role develops integrated access strategies and launch-readiness plans that account for payer, provider, employer, reimbursement, guideline, evidence, and stakeholder realities. It also identifies risks and opportunities, coordinates governance and workstreams, and communicates recommendations, assumptions, resource needs, and risks to senior leaders. This is a hybrid position requiring three days per week at one of four offices: Thousand Oaks, California; El Segundo, California; Foster City, California; or Parsippany, New Jersey.

Requirements

  • Advanced scientific degree such as MD, PharmD, or PhD and at least 8 years of experience; or a master’s degree and at least 10 years of experience; or a bachelor’s degree and at least 12 years of experience.

Nice To Haves

  • At least 10 years of relevant pharmaceutical or biotechnology experience in market access, launch planning, new product planning, payer strategy, global market access, commercial strategy, HEOR, or related roles.
  • Experience supporting launch planning or new product planning for specialty, oncology, hematology, or cell therapy products.
  • Strong understanding of US market access, payer coverage, provider economics, reimbursement, guideline dynamics, evidence requirements, and buy-and-bill access considerations.
  • Experience working with global teams and influencing development, evidence, market research, and commercialization planning.
  • Ability to lead complex cross-functional workstreams without direct authority.
  • Strong strategic thinking and analytical skills, including identifying access risks early and translating them into practical mitigation plans.
  • Experience developing launch readiness plans, launch workstreams, executive updates, and governance processes.
  • Deep understanding of CAR T, hematology/oncology, or specialty therapy market dynamics.
  • High emotional intelligence and situational awareness, with the ability to collaborate effectively across functions and senior leaders.
  • Strong project management skills, including managing multiple assets, deadlines, and stakeholders.
  • Advanced PowerPoint and Excel skills.
  • Excellent verbal and written communication skills.

Responsibilities

  • Serve as the US Market Access lead for pipeline assets and new product planning activities.
  • Represent US Market Access in global and cross-functional planning forums concerning pipeline assets, new indications, lifecycle opportunities, and future launch priorities.
  • Develop integrated US access strategies for pipeline assets, considering payer, provider, reimbursement, evidence, employer, policy, and market-readiness factors.
  • Identify potential access risks and opportunities early in development and recommend mitigation strategies.
  • Ensure US Market Access perspectives are included in global development plans, commercialization assumptions, evidence plans, value strategy, product positioning, and launch planning.
  • Lead Market Access launch planning for future assets and indications and align relevant US Market Access functions.
  • Develop and maintain launch access workplans, milestones, readiness scorecards, and executive updates.
  • Partner with Provider Access Marketing and Payer & Value Marketing to identify launch resources, customer tools, value materials, and stakeholder education needs.
  • Partner with Pricing & Contracting and Trade to ensure launch planning reflects expected pricing, contracting, distribution, reimbursement, and operational requirements.
  • Ensure readiness plans cover the first 30, 60, 90, and 180 days after approval, including payer coverage, provider readiness, field enablement, customer resources, and access operations.
  • Serve as a primary US Market Access interface to Global Market Access and applicable global asset teams.
  • Provide US access input to global launch planning, market research, evidence generation, payer research, value proposition development, and commercialization strategy.
  • Work with global and US teams to ground launch assumptions in US payer, provider, employer, reimbursement, and access dynamics.
  • Influence cross-functional teams to prioritize access activities critical to launch success.
  • Keep US Market Access leadership informed about pipeline decisions, launch tradeoffs, risks, and resource needs.
  • Partner with HEOR, Medical Affairs, Regulatory, Global Market Access, and Payer & Value Marketing to identify payer and provider evidence needs.
  • Identify evidence gaps that could affect coverage, reimbursement, guideline inclusion, provider adoption, or stakeholder confidence at launch.
  • Support development of payer evidence requirements, value narrative considerations, and launch-related evidence translation priorities.
  • Work with internal teams to incorporate Market Access perspectives into NCCN and guideline planning discussions where appropriate.
  • Ensure launch planning reflects the anticipated evidence package, competitive profile, indication, patient population, and access-relevant clinical considerations.
  • Develop integrated launch access blueprints for pipeline assets and launch opportunities.
  • Establish governance routines and cross-functional workstreams to support Market Access launch readiness.
  • Partner with Portfolio & Strategic Planning to incorporate new product and launch priorities into broader US Market Access planning.
  • Provide clear, decision-oriented updates to US Market Access Leadership and cross-functional senior leaders.
  • Create executive-level materials communicating launch risks, access assumptions, resource needs, and recommended actions.
  • Model inclusive leadership, foster belonging, coach and develop employees, align teams to organizational priorities, remove barriers, and encourage accountability in accordance with People Leader Accountabilities.

Benefits

  • May be eligible for a discretionary annual bonus.
  • May be eligible for discretionary stock-based long-term incentives; eligibility may vary by role.
  • Paid time off.
  • Company-sponsored medical insurance.
  • Company-sponsored dental insurance.
  • Company-sponsored vision insurance.
  • Company-sponsored life insurance.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service